U.S. Electronic Equipment and Components Stock News

Ondas FY 2025 results set the stage for a tighter focus on profitability Ondas (ONDS) just posted its FY 2025 numbers with third quarter revenue at about US$10.1 million and a basic EPS loss of US$0.03, alongside trailing twelve month revenue of roughly US$24.7 million and a cumulative net loss of about US$47.7 million. Over recent quarters, the company has seen revenue move from around US$0.96 million in Q2 2024 to US$1.48 million in Q3 2024, then to US$4.25 million in Q1 2025, US$6.27...

Anyone interested in HBT Financial, Inc. ( NASDAQ:HBT ) should probably be aware that the Director, Patrick Busch...

Shareholders appeared unconcerned with DocuSign, Inc.'s ( NASDAQ:DOCU ) lackluster earnings report last week. We think...

Axogen (AXGN) is back in focus after management highlighted expectations for 20% revenue growth in 2025, expanded reimbursement coverage and FDA approval of a key nerve repair product, along with anticipated positive free cash flow in 2026. See our latest analysis for Axogen. The latest operational update and FDA approval news have come against a backdrop of mixed share price performance, with a 5.2% year to date share price return but a very strong 1 year total shareholder return of 71.7%...

Recursion Pharmaceuticals (NasdaqGS:RXRX) has appointed Vicki Goodman, M.D., as Chief Medical Officer, effective April 6, 2026. Dr. Goodman succeeds David Mauro, M.D., Ph.D., and brings more than 20 years of oncology drug development leadership. Her background includes senior roles at Mural Oncology, Exelixis, Merck, Bristol Myers Squibb, and GlaxoSmithKline, with experience on major oncology products such as KEYTRUDA, OPDIVO, and YERVOY. For investors tracking Recursion Pharmaceuticals at...

Over the last 7 days, the United States market has dropped 2.3%, yet it remains up by 13% over the past year with earnings expected to grow by 16% annually. In this context, identifying high growth tech stocks involves looking for companies that demonstrate robust innovation and adaptability, positioning themselves well amidst fluctuating market conditions.

Over the last 7 days, the United States market has experienced a 2.3% decline, yet it remains up by 13% over the past year with earnings projected to grow by 16% annually. In this context, identifying stocks that are potentially priced below their intrinsic value can be a prudent strategy for investors seeking opportunities amidst fluctuating market conditions.

Over the last 7 days, the United States market has experienced a 2.3% decline, yet it remains up by 13% over the past year with earnings forecasted to grow by 16% annually. In this context of fluctuating conditions and promising growth prospects, identifying stocks with high insider ownership can be advantageous as it often signals confidence from those closely tied to a company's success.

Over the last 7 days, the U.S. market has dropped 2.3%, though it has risen by 13% over the past year, with earnings expected to grow by 16% per annum in the coming years. In light of these conditions, identifying stocks with strong fundamentals becomes crucial, particularly when exploring opportunities outside mainstream investments. Although "penny stocks" is a somewhat outdated term, it still refers to smaller or less-established companies that can offer significant potential; here we...

Over the last 7 days, the United States market has experienced a slight decline of 2.3%, although it has shown resilience with a 13% rise over the past year and an optimistic forecast of 16% annual earnings growth. In this dynamic environment, identifying stocks with strong potential often involves looking beyond well-known names to find those undiscovered gems that align with current growth trends and market conditions.

Over the last 7 days, the United States market has dropped 2.3%, yet it remains up by 13% over the past year with earnings forecasted to grow by 16% annually. In such a dynamic environment, selecting dividend stocks with reliable yields can provide stability and income potential for investors seeking to navigate market fluctuations.

Wondering whether Safety Insurance Group at around US$73.39 is a sensible entry or hold for you right now? This article focuses squarely on what the current price might imply about value. The stock has been fairly steady in the very short term with a 0.8% return over the last week. The past month shows a 6.4% decline and the year-to-date return sits at a 3.1% decline, alongside a 1.7% decline over the past year, a 14.6% return over three years and a 7.8% return over five years. Recent...

If you are wondering whether Helios Technologies at around US$67.54 is still attractively priced after a big run, the key question is what you are really paying for today. The stock has moved 4.0% over the last 7 days, sits on a year to date return of 23.5%, and has delivered 98.3% over the last year, although the past 30 days show a 9.0% decline that may have shifted perceptions of risk and opportunity. Recent coverage around Helios Technologies has focused on how its share price...

In March 2026, Compass Minerals International, Inc. completed the full redemption of the US$150,000,000 aggregate principal amount of its 6.750% Senior Notes due 2027 using cash on hand, paying 100% of principal plus accrued interest to the redemption date. This move marks an acceleration of the company’s balance sheet transformation and debt reduction efforts, which may enhance financial flexibility and lower interest costs. We’ll now examine how this accelerated debt redemption shapes...

Klaviyo (NYSE:KVYO) has launched Composer, an AI-driven agentic tool designed to build full marketing campaigns. The company also rolled out expanded Customer Agent capabilities and more than 75 new features across marketing, data, analytics, and customer service. These changes represent a broad update to Klaviyo's marketing automation platform, aimed at unifying workflows and customer data. Klaviyo operates in marketing automation and customer engagement, an area where brands are looking...

MongoDB (NasdaqGM:MDB) has appointed Ryan Mac Ban as Chief Revenue Officer. The new CRO is tasked with driving the next phase of growth in AI and cloud data markets. This leadership change follows other recent executive additions at the company. For investors watching MongoDB, the new CRO role sits at the center of how the company turns demand for AI and multi cloud data platforms into actual revenue. MongoDB focuses on modern database and developer data tools that are widely used in cloud...

Wondering whether Prosperity Bancshares at around US$66 is offering good value today, or if the price already reflects its strengths? This article breaks down what the numbers are really saying about the stock. The share price is around US$66.41 after a recent 2.9% gain over the last 7 days, set against a 9.7% decline over 30 days and a 4.6% decline year to date and over 1 year, with a 3 year return of 18.6% and 5 year return of 2.8%. Recent coverage has focused on how Prosperity Bancshares...

If you are wondering whether Ocugen's current share price still makes sense after a strong run, the key question is how that price lines up with the underlying value of the business. Ocugen shares, which last closed at US$1.92, have had a mixed but attention grabbing run, with a 21.6% decline over the last 7 days, a 20.0% gain over 30 days, 39.1% year to date, 168.6% over 1 year and 131.3% over 3 years, set against a 71.6% loss over 5 years. Recent news coverage has focused on Ocugen's...

Hesai Group (NasdaqGS:HSAI) has just posted its FY 2025 third quarter numbers, with revenue of C¥795.4 million and basic EPS of C¥1.88 setting the tone for the latest update. The company has seen quarterly revenue move from C¥458.9 million in Q2 2024 to C¥719.8 million in Q4 2024 and then to C¥795.4 million in Q3 2025. Basic EPS has shifted from a loss of C¥0.56 per share in Q2 2024 to C¥1.13 in Q4 2024 and C¥1.88 in Q3 2025, pointing to a business where margins are increasingly in focus for...

Last week's earnings announcement from Turtle Beach Corporation ( NASDAQ:TBCH ) was disappointing to investors, with a...

Two Harbors Investment Corp. (NYSE:TWO) has received unsolicited acquisition proposals that the board is formally reviewing. The board has identified at least one proposal as a potential "Company Superior Proposal" under its existing merger agreement with UWMC. These proposals could affect the outcome of the current merger plan and may alter the future ownership structure of NYSE:TWO. Two Harbors Investment Corp. operates as a real estate investment trust focused on mortgage related assets,...

Wondering whether AppFolio at around US$161.05 still makes sense as an investment, or if the recent price puts it out of your comfort zone on value. The stock has seen a 4.4% decline over the last 7 days, a 6.5% decline over 30 days, and a 30.1% decline year to date and over 1 year, while the 3 year and 5 year returns sit at 34.0% and 16.5% respectively. Recent coverage has focused on how the year to date and 1 year share price performance of 30.1% may be influencing investor sentiment...

Earlier this year, Unum Group expanded its Unum Broker Connect integration with Employee Navigator to add automated billing and eligibility features, aiming to cut manual work and improve accuracy for brokers and employers managing benefits and leave. By automating eligibility data flows into Unum Total Leave, the company is positioning its benefits platform as a more integrated solution for employers grappling with increasingly complex leave management. We’ll now explore how this expanded...

If you are wondering whether Merit Medical Systems at around US$67.55 is starting to look appealing or still feels expensive, the recent share performance gives you a useful starting point. The stock has seen a 3.8% decline over the last 7 days, a 17.8% fall over the last 30 days, and is down 21.9% year to date and 35.5% over the past year, while the 5 year return stands at 13.4%. These moves have put more attention on how the market currently prices Merit Medical Systems and whether...